NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, and led by Professor Paolo A. Ascierto of the Istituto Na ...

AI may help radiologists evaluate mammograms for breast cancer more effectively, but researchers at UCLA, UC Davis and ...

People who had a daily cup of coffee had a lower risk of new episodes of atrial fibrillation compared with people who ...

NEW ORLEANS -- The investigational oral PCSK9 inhibitor enlicitide reduced low-density lipoprotein (LDL) cholesterol in ...

A total of 399 patients underwent TEE and were taking their assigned treatment at 60 days follow-up.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...

Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new ...

Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

About 50% of people don't respond to first-line treatments for depression. There's a lot of heterogeneity of treatment ...

Those who have undergone successful corrective procedures for irregular heart beats may no longer need to commit to long-term blood thinning therapy, an international study co-led by Canadian ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...